GLP-1 Agonists Reduce Recurrent Atrial Fibrillation
Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report investigators who say weight loss does not fully explain the benefit.
Patients taking a GLP-1 for diabetes have a lower risk for AF at 3 years than those on other medications, report investigators who say weight loss does not fully explain the benefit.
A popular fat found in olive oil may not be as innocent as it seems. Scientists discovered that oleic acid, a major component of many…
A new study suggests recommending the vaccine at ages 9-10 years is not only practical for clinics but could increase uptake for the multi-dose shot.
Governor Jared Polis signs Senate Bill 25-048 into law, expanding insurance coverage for obesity and diabetes treatment in Colorado.
Patients who survive a heart attack often need coordinated care to address the mental, not just physical, aftermath.
The novel oral polio vaccine type 2 elicits intestinal immune responses similar to those induced by the traditional Sabin monovalent oral polio vaccine type 2,…
Drs Glatter, Herbert, Ho, and Cozzi discuss The Pitt and how it captures the real-life intensity, trauma, and teamwork that define emergency medicine today.
Nordic prisons get lots of good press, but the data show a high mental health burden. Medscape Medical News asks why.
Rising temperatures in recent years were associated with increased incidence of OSA worldwide.
Long-acting muscarinic antagonists, as add-on therapy to inhaled corticosteroids, improve lung function parameters and reduce exacerbations in children younger than 12 years with moderate-to-severe asthma.
Disability bias in pediatric care is keeping some families from getting medical help when they need it.